Optimal glucocorticoid replacement therapy in adrenocorticotropin (ACTH) deficient hypopituitary patients - Optimal glucocorticoid replacement Optimal glucocorticoid replacement therapy in adrenocorticotropin (ACTH) deficient hypopituitary pat ...
Optimal glucocorticoid replacement therapy in adrenocorticotropin (ACTH) deficient hypopituitary patients - Optimal glucocorticoid replacement Optimal glucocorticoid replacement therapy in adrenocorticotropin (ACTH) deficient hypopituitary pat ...
10 male patients with hypopituitarism resulting in ACTH (adrenocorticotropin) deficiency (ICD E23.0) will be studied on varying doses of hydrocortisone replacement therapy. THis is not a new medication for these patients.10 healthy male volunteers will be studied as control subjects. They will NOT receive hydrocortisone. MedDRA version: 9.1;Level: LLT;Classification code 10021067;Term: Hypopituitarism MedDRA version: 9.1;Classification code 10033662;Term: Panhypopituitarism MedDRA version: 9.1;Classification code 10057217;Term: Isolated ACTH deficiency 10 male patients with hypopituitarism resulting in ACTH(adrenocorticotropin) deficiency (ICD E23.0) ...